FDA.reportPublic FDA data

10 ML irinotecan hydrochloride liposome 4.3 MG/ML Injection

RxCUI
1719772
RxNorm name
10 ML irinotecan hydrochloride liposome 4.3 MG/ML Injection
Display name
10 ML irinotecan hydrochloride liposome 4.3 MG/ML Injection
Full name
10 ML irinotecan hydrochloride liposome 4.3 MG/ML Injection
Term type
SCD
Status
DailyMed mapping
Updated
2026-06-04 23:39:20

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
OnivydeIRINOTECAN HYDROCHLORIDEIpsen Biopharmaceuticals, Inc.c8b58efa-1820-48a4-b70d-62918fc4abfc2025-03-03Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 1719772

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
c8b58efa-1820-48a4-b70d-62918fc4abfcirinotecan HCl liposome 43 MG in 10 ML Injection [PSN] · 10 ML irinotecan hydrochloride liposome 4.3 MG/ML Injection [SCD] · irinotecan hydrochloride liposome 43 MG per 10 ML Injection [SY]39These highlights do not include all the information needed to use ONIVYDE safely and effectively. See full prescribing information for ONIVYDE ONIVYDE® (irinotecan liposome injection), for intravenous use Initial U.S. Approval: 199620250303